A new model of Cuprizone-Mediated demyelination/remyelination

ASN Neuro

Volumn 6, Issue 5, 2014, Pages

  Sachs, Hilary H ^a   Bercury, Kathryn K ^a   Popescu, Daniela C ^b,c   Narayanan, S Priya ^b,d   Macklin, Wendy B ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c KENT STATE UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Akt; Cuprizone; Demyelination; MTOR; Oligodendrocyte; Rapamycin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CUPRIZONE; PROTEIN KINASE B; RAPAMYCIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; IMMUNOSUPPRESSIVE AGENT; KI 67 ANTIGEN; MONOAMINE OXIDASE INHIBITOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE PROTEIN; OLIG2 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; REMYELINIZATION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; ANALYSIS OF VARIANCE; ANIMAL; BODY WEIGHT; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DEMYELINATING DISEASE; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; MYELIN SHEATH; PATHOLOGY; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BODY WEIGHT; BRAIN; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE INHIBITORS; MYELIN SHEATH; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIROLIMUS;

EID: 84940094081     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091414551955     Document Type: Article

References (55)

1. Avruch J., Long X., Ortiz-Vega S., Rapley J., Papageorgiou A., and Dai N. (2009) Amino acid regulation of TOR complex 1. American Journal of Physiology Endocrinology and Metabolism 296: E592-E602.
2. Bercury K. K., Dai J., Sachs H. H., Ahrendsen J. T., Wood T. L., and Macklin W. B. (2014) Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. The Journal ofNeuroscience: The Official Journal of the Society for Neuroscience 34: 4466-1480.
3. Chen Y. C., Lo C. L., Lin Y. F., and Hsiue G. H. (2013) Rapamycin encapsulated in dual-responsive micelles for cancer therapy. Biomaterials 34: 1115-1127.
4. Cho K. H. (2011) Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 66: 1274-1285.
5. Cloetta D., Thomanetz V., Baranek C., Lustenberger R. M., Lin S., Oliveri F., Ruegg M. A. (2013) Inactivation of mTORCl in the developing brain causes microcephaly and affects gliogen-esis. The Journal ofNeuroscience: The Official Journal ofthe Society for Neuroscience 33: 7799-7810.
6. Deverman B. E., and Patterson P. H. (2012) Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. The Journal ofNeuroscience: The Official Journal ofthe Society for Neuroscience 32: 2100-2109.
7. Dutta R., and Trapp B. D. (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-S31.
8. Flores A. I., Narayanan S. P., Morse E. N., Shick H. E., Yin X., Kidd G., Macklin W. B. (2008) Constitutively active Akt induces enhanced myelination in the CNS. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28: 7174-7183.
9. Franklin K., and Paxinos G. (2008) The mouse brain in stereotaxic coordinates. San Diego, CA: Academic press.
10. Fyffe-Maricich S. L., Schott A., Karl M., Krasno J., and Miller R. H. (2013) Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system. The Journal ofNeuroscience: The Official Journal ofthe Society for Neuroscience 33: 18402-18408.
11. Goldberg J., Daniel M., van Heuvel Y., Victor M., Beyer C., Clarner T., … Kipp M. (2013) Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes. Cellular and Molecular Neurobiology 33: 1087-1098.
12. Hibbits N., Yoshino J., Le T. Q., and Armstrong R. C. (2012) Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4: 393-408.
13. Hiremath M. M., Saito Y., Knapp G. W., Ting J. P., Suzuki K., and Matsushima G. K. (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. Journal ofNeuroimmunology 92: 38-49.
14. Hollander H., and Vaaland J. L. (1968) A reliable staining method for semi-thin sections in experimental neurfanatomy. Brain Research 10: 120-126.
15. Ishii A., Furusho M., and Bansal R. (2013) Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. The Journal of Neuroscience: The Official Journal ofthe Society for Neuroscience 33: 175-186.
16. Kipp M., Clarner T., Dang J., Copray S., and Beyer C. (2009) The cuprizone animal model: New insights into an old story. Acta Neuropathologica 118: 723-736.
17. Lindner M., Fokuhl J., Linsmeier F., Trebst C., and Stangel M. (2009) Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neuroscience Letters 453: 120-125.
18. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Stangel M. (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathology and Applied Neurobiology 34: 105-114.
19. Linthicum D. S., Mackay I. R., Wilson A., Horvath L. B., and Carnegie P. R. (1981) Detection of antibodies to central nervous Journals of Gerontology Series A, Biological Sciences and Medical Sciences 66: 1274-1285.
20. Cloetta D., Thomanetz V., Baranek C., Lustenberger R. M., Lin S., Oliveri F., Ruegg M. A. (2013) Inactivation of mTORCl in the developing brain causes microcephaly and affects gliogen-esis. The Journal of Neuroscience: The Official Journal ofthe Society for Neuroscience 33: 7799-7810.
21. Deverman B. E., and Patterson P. H. (2012) Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. The Journal of Neuroscience: The Official Journal ofthe Society for Neuroscience 32: 2100-2109.
22. Dutta R., and Trapp B. D. (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-S31.
23. Flores A. I., Narayanan S. P., Morse E. N., Shick H. E., Yin X., Kidd G., Macklin W. B. (2008) Constitutively active Akt induces enhanced myelination in the CNS. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28: 7174-7183.
24. Franklin K., and Paxinos G. (2008) The mouse brain in stereotaxic coordinates. San Diego, CA: Academic press.
25. Fyffe-Maricich S. L., Schott A., Karl M., Krasno J., and Miller R. H. (2013) Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system. The Journal of Neuroscience: The Official Journal ofthe Society for Neuroscience 33: 18402-18408.
26. Goldberg J., Daniel M., van Heuvel Y., Victor M., Beyer C., Clarner T., Kipp M. (2013) Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes. Cellular and Molecular Neurobiology 33: 1087-1098.
27. Hibbits N., Yoshino J., Le T. Q., and Armstrong R. C. (2012) Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4: 393-408.
28. Hiremath M. M., Saito Y., Knapp G. W., Ting J. P., Suzuki K., and Matsushima G. K. (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. Journal ofNeuroimmunology 92: 38-49.
29. Hollander H., and Vaaland J. L. (1968) A reliable staining method for semi-thin sections in experimental neurfanatomy. Brain Research 10: 120-126.
30. Ishii A., Furusho M., and Bansal R. (2013) Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. The Journal ofNeuroscience: The Official Journal of the Society for Neuroscience 33: 175-186.
31. Kipp M., Clarner T., Dang J., Copray S., and Beyer C. (2009) The cuprizone animal model: New insights into an old story. Acta Neuropathologica 118: 723-736.
32. Lindner M., Fokuhl J., Linsmeier F., Trebst C., and Stangel M. (2009) Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neuroscience Letters 453: 120-125.
33. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Stangel M. (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathology and Applied Neurobiology 34: 105-114.
34. Linthicum D. S., Mackay I. R., Wilson A., Horvath L. B., and Carnegie P. R. (1981) Detection of antibodies to central nervous system antigens by solid phase radioimmunoassay. Journal of Neuroscience Research 6: 567-578.
35. Matsushima G. K., & Morell P. (2001) The neurotoxicant, cupri-zone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology 11: 107-116.
36. Narayanan S. P., Flores A. I., Wang F., & Macklin W. B. (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. The Journal ofNeuroscience: The Official Journal of the Society for Neuroscience 29: 6860-6870.
37. Paintlia M. K., Paintlia A. S., Singh A. K., & Singh I. (2013) S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions. The Journal of Biological Chemistry 288: 3831-3843.
38. Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Sabatini D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 22: 159-168.
39. Shin H. C., Alani A. W., Cho H., Bae Y., Kolesar J. M., & Kwon G. S. (2011) A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs. Molecular Pharmaceutics 8: 1257-1265.
40. Skripuletz T., Gudi V., Hackstette D., & Stangel M. (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected. Histology and Histopathology 26: 1585-1597.
41. Skripuletz T., Hackstette D., Bauer K., Gudi V., Pul R., Voss E., Stangel M. (2013) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain: A Journal ofNeurology136: 147-167.
42. Stallcup W. B. (1981) The NG2 antigen, a putative lineage marker: Immunofluorescent localization in primary cultures of rat brain. Developmental Biology 83: 154-165.
43. Tansey F. A., & Cammer W. (1991) A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. Journal ofNeurochemistry 57: 95-102.
44. Torkildsen O., Brunborg L. A., Thorsen F., Mork S. J., Stangel M., Myhr K. M.,… Bo L. (2009) Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Experimental Neurology 215: 160-166.
45. Trapp B. D., Nishiyama A., Cheng D., & Macklin W. (1997) Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. The Journal ofCell Biology 137: 459-468.
46. Tsiperson V., Li X., Schwartz G. J., Raine C. S., and Shafit-Zagardo B. (2010) GAS6 enhances repair following cuprizone-induced demyelination. PloS One 5: e15748.
47. Tyler W. A., Gangoli N., Gokina P., Kim H. A., Covey M., Levison S. W., Wood T. L. (2009) Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 29: 6367-6378.
48. van Vliet E. A., Forte G., Holtman L., den Burger J. C., Sinjewel A., de Vries H. E., Gorter J. A. (2012) Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia 53: 1254-1263.
49. Voss E. V., Skuljec J., Gudi V., Skripuletz T., Pul R., Trebst C., Stangel M. (2012) Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? Neurobiology of Disease 45: 519-528.
50. Wergeland S., Torkildsen O., Myhr K. M., Aksnes L., Mork S. J., and Bo L. (2011) Dietary vitamin D3 supplements reduce demye-lination in the cuprizone model. PloS One 6: e26262.
51. Xie L., Sun F., Wang J., Mao X., Xie L., Yang S. H., Jin K. (2014) mTOR signaling inhibition modulates macrophage/ microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. Journal of Immunology 192: 6009-6019.
52. Xie M., Tobin J. E., Budde M. D., Chen C. I., Trinkaus K., Cross A. H., Armstrong R. C. (2010) Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. Journal of Neuropathology and Experimental Neurology 69: 704-716.
53. Yoshikawa K., Palumbo S., Toscano C. D., and Bosetti F. (2011) Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage. Prostaglandins, Leukotrienes, and Essential Fatty Acids 85: 43-52.
54. Zeng L. H., Xu L., Gutmann D. H., and Wong M. (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Annals ofNeurology 63: 444-453.
55. Zou J., Zhang X., Yang H., Zhu Y., Ma H., and Wang S. (2011) Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts. Journal of Cardiothoracic Surgery 6: 69.